Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).
Study Type
OBSERVATIONAL
Enrollment
380
CHRU Amiens
Amiens, France
RECRUITING90-day all-cause mortality
Time frame: 90 days
90-day mortality in oncologic vs. non-oncologic thoracic surgery
Time frame: 90 days
Postoperative complication rates
Postoperative complication rates (hemorrhagic, thrombotic, infectious)
Time frame: 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.